http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014084378-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_faf522b8b83eded745c73018576219ba
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-755
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-243
filingDate 2013-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_906dbbb1f7a47c478969fb95dadfc81c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac2314e883a9c886f5b6466d12bcaea4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6ef6a4daf5f985c66ce1fbebe2d32a6
publicationDate 2014-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2014084378-A1
titleOfInvention Anticancer drug comprising cyclic rgd sequence-containing peptide
abstract Provided is an anticancer drug which has advantages such as reduced gastrointestinal toxicity and less weight loss in patients. This anticancer drug comprises an anti-cancer active ingredient and a cyclic arginine-glycine-aspartic acid (RGD) sequence-containing peptide.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2017002979-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7281140-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10328116-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10946028-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021035972-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2017110669-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2022529413-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017537974-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017002979-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017110669-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2721725-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020213015-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2014157584-A1
priorityDate 2012-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467664054

Total number of triples: 43.